These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets]. Dvorácková K, Rabisková M, Masteiková R, Vocilková L. Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525 [Abstract] [Full Text] [Related]
4. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. Hayashi T, Kanbe H, Okada M, Kawase I, Ikeda Y, Onuki Y, Kaneko T, Sonobe T. Int J Pharm; 2007 Aug 16; 341(1-2):105-13. PubMed ID: 17512147 [Abstract] [Full Text] [Related]
7. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation. Khan F, Ibn Razzak SM, Khan ZR, Azad MA, Chowdhury JA, Reza S. Pak J Pharm Sci; 2009 Apr 16; 22(2):155-61. PubMed ID: 19339225 [Abstract] [Full Text] [Related]
8. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets. Jonkman JH, van der Boon WJ, Schoenmaker R, Holtkamp A, Thürkow-Luikens AJ. Int J Clin Pharmacol Ther Toxicol; 1984 Sep 16; 22(9):506-10. PubMed ID: 6500770 [Abstract] [Full Text] [Related]
9. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer. Ochoa L, Igartua M, Hernández RM, Gascón AR, Pedraz JL. J Pharm Pharm Sci; 2005 Jun 29; 8(2):132-40. PubMed ID: 16124924 [Abstract] [Full Text] [Related]
13. [Comparative bioavailability of 2 oral theophylline sustained-release preparations]. Tritthart W, Lücker PW, Fáy E, Buchebner J. Arzneimittelforschung; 1983 Jun 29; 33(11):1603-6. PubMed ID: 6686457 [Abstract] [Full Text] [Related]
14. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans. Harrison LI, French IW, Mildon CA. Clin Ther; 1982 Jun 29; 4(6):489-96. PubMed ID: 7093982 [Abstract] [Full Text] [Related]
15. [Formulation of slow-release tablets. III. Lipid matrices]. Doelker E, Buri P. Pharm Acta Helv; 1981 Jun 29; 56(4-5):111-8. PubMed ID: 7255497 [No Abstract] [Full Text] [Related]
18. Alteration of pharmacokinetics after halving a slow-release theophylline tablet. Primrose WR, Clee MD, Moody JP, Hockings N. Pharmatherapeutica; 1983 Jun 29; 3(6):429-32. PubMed ID: 6622502 [Abstract] [Full Text] [Related]
19. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Gai MN, Isla A, Andonaegui MT, Thielemann AM, Seitz C. Int J Clin Pharmacol Ther; 1997 Dec 29; 35(12):565-71. PubMed ID: 9455715 [Abstract] [Full Text] [Related]
20. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations]. Frömming KH, Schwabe L, Staib AH, Rietbrock N, Lassmann A, Molz KH, Schuppan D, Siebert-Weigel M, Voegele D. Arzneimittelforschung; 1983 Dec 29; 33(3):446-52. PubMed ID: 6683521 [Abstract] [Full Text] [Related] Page: [Next] [New Search]